Replies to post #21445 on RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

Near zero.

Re: Prialt/ziconotide/SNX-111. That's been available for four years. It's been a disappointment, mainly because it's very easy to get serious cognitive side effects. No RD risk that I know of, but it's never become anything near the competitive factor that it was expected to be back in its Neurex 'snail juice' days.

NeuroInvestment